Avoiding the ‘Eagle Trap’ in pharma product launches

Authored by: Matt Riordan & Brian Stamm

Inizio Ignite examined approximately 200 recent product launches and tracked performance against consensus forecasts at launch. The analysis revealed that 55% of launches were identified as Underperformers, while only 23% were Overperformers.  Surprisingly, underperformance was just as present in highly differentiated products as it was in products with low clinical differentiation.

So why is this happening? The answer is not a lack of effort or expertise; it’s often a pattern we call the “Eagle Trap.”

The Eagle Trap

There’s an old proverb: if an eagle chases two rabbits, it will catch none. The Eagle Trap is a modern version of that warning, a recurring pattern where a team tries to do too many things and successfully achieves none. Picture an eagle spotting opportunity everywhere with two paths to growth, two priority segments, two stories to tell, and committing to both. It may look ambitious, but it ends in a miss. It causes diluted effort, inconsistent execution, and a market that never quite understands what the brand stands for.

In the resource-intensive pharmaceutical industry most launches do not fail because teams do too little. The truth is many fail to meet expectations because they try to do too much, too soon. That is the Eagle Trap.

How launch teams get overextended

Too often in our industry, we see an overextended team. Though the goal may often start as reasonable, with the aim of maximizing the addressable market, focus can begin to drift well before launch. During planning and pre-launch implementation, teams uncover additional subpopulations, adjacent lines of therapy, and promising micro-segments. Add internal pressure to satisfy multiple functions and geographies, and the plan expands again and again.

It’s at this point that the cost of this loss of focus becomes apparent. It results in additional operational complexity and a loss of strategic coherence. When brand positioning tries to be everything at once, it becomes easier for stakeholders to dismiss it as interchangeable, so field teams compensate by improvising. Medical engagement has plenty of tactics but lacks a cohesive strategic focus.  Access narratives don’t align with marketing positioning and patient identification, and support efforts compete for attention. What began as an effort to maximize launch impact ultimately erodes success – and that loss of focus is often where underperformance begins.

Where does the Eagle Trap first become visible?

The Eagle Trap rarely becomes evident on day one. Early dashboards often look reassuring because activity is high, campaigns are live, materials are plentiful, and field engagement is strong. But over time, the signals start to diverge. Post-launch measurement reveals uneven uptake across priority segments, message recall that varies by channel and geography, and a growing gap between what the brand team thinks is being communicated and what customers are actually hearing.

Avoiding the trap

Avoiding the Eagle Trap starts with upstream prioritization, making explicit, protected trade-offs. Our experts have observed that brands that manage to escape it downstream do things differently upstream.

Focus investment

High-performing teams must be willing to make tradeoffs. This means ruthlessly prioritizing to achieve deliberate focus on target customers, segments, and messages, resisting over-fragmentation. This focus is then translated into strategic investment: declutter where customers are overserved by simplifying messages and channels. Conversely, focus investment at points in the patient journey where customers are underserved. These points commonly include disease awareness and characterization, access and funding, diagnosis, referral, treatment, and adherence and monitoring.

Pick battles early

Teams must pick their battles early. Instead of defaulting to a standard launch process that tries to serve every audience, they should get specific about what must change for the launch to succeed in year one. They determine which decision moves first and in which population they will prove value before they broaden. They are willing to double down on priority objectives even if it means hitting pause on secondary objectives.  Clarity in these areas permits teams to be agile in tactics while staying resolute on strategy.

The top-performing teams stay focused when the plan starts to sprawl. They choose a small number of customer groups and a small number of messages they want the market to remember. They repeat them consistently enough for the story to travel intact across channels, geographies, and functions.

Disciplined execution

That focus only pays off if it is translated into disciplined execution. In practice, this is where many launches break down. Strategy, execution, and performance are often managed as separate workstreams rather than as a connected system.

Launch acceleration doesn’t come from doing more: Focus beats volume, integration beats activity, and discipline beats urgency.

To turn strategy into disciplined execution, three core tenets must be protected:

1. Protecting simplicity – learn to say ‘no’

Launching a product is not a copy-and-paste scenario. Teams must identify the 5 to 10 deliverables that cannot slip and ensure the entire team knows what must happen to achieve success. Acceleration comes from removing noise, not from adding activity.

2. Enabling decision-driving governance

When governance is informational, execution stalls, decisions drift, escalations are delayed, and accountability blurs. Governance must be designed not only for transparency but also for decision velocity. Leaders must ensure they have the right people in the room, as a consensus culture cannot delay decisions.

3. Planning for multiple future scenarios

The most successful launch teams rehearse the future before it happens. This means mapping approval scenarios, label variations, and competitive responses, ensuring Day 0 isn’t improvized but a well-rehearsed milestone.

Actionable next step

The launches that outperform are rarely the ones that try to win everything at once. They establish coherence up front, learn quickly, and expand deliberately.

In summary, we’ve found that teams who pause to reassess where they’re overextended can quickly refocus impact – often by deprioritizing one or two areas and doubling down where it matters most. When that isn’t obvious, returning to core market metrics and the end-to-end customer journey typically reveals where focus is being lost – and where sharper execution can make the biggest difference.

Learn more about how we’re delivering a connected launch system so our clients can create greater impact here.